IBC Protocol Submission Platform
All research involving recombinant or synthetic nucleic acid molecules, biological materials, infectious agents, and/or select agents or toxins conducted at UTEP must be reviewed and approved by the Institutional Biosafety Committee (IBC) before the work begins.
Submisions are trough
IBC Submission Process.
